NICE Recommends Five AI Tools for Prostate MRI Scans
The National Institute for Health and Care Excellence (NICE) recommends five AI tools for prostate MRI scans under draft guidance, according to Digital Health. AI-Rad Companion Prostate MR, DeepHealth Prostate, ProstatID, Prostate Intelligence (Pi) and QP-Prostate can be used in the NHS during a two year evidence collection period.
The tools highlight areas where cancer might be present to support radiologists reviewing and reporting scans. NICE said they could improve the accuracy and consistency of MRI interpretation, particularly where specialist expertise is unavailable. NHS national clinical director for cancer Peter Johnson said a radiologist will still review every scan.
The evidence period will assess performance in routine NHS practice and across patient groups. NICE did not recommend hProstate or mdprostate for NHS funding because clinical and cost effectiveness evidence was unavailable.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Policy Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Regulation
Oct 23 Pentagon Issues AI Procurement Guidance on Ideological Neutrality Oct 23 Sweden's Government Offices Block ChatGPT and Claude on Work Computers Oct 23 US Treasury proposes expanded outbound investment controls for AI Oct 23 UK AI Minister Calls for Regulation and Domestic AI Capacity Oct 23 China Approves DeepSeek and MiniMax Models for Overseas UseMore from Life Sciences
Oct 23 Boehringer Ingelheim and Microsoft to Study Digital Patient Twins Oct 23 Coreline Soft Receives FDA Clearance for Aortic CT Analysis Software Oct 23 Ping An Good Doctor Profit Rises 35% as AI Doctor Users Near 13 Million Oct 22 Microsoft GPT-5 Diagnostic System Outperforms Doctors in Science Study Oct 22 BioStack Raises $9.5 Million for Medical AI Data NetworkAI Policy Brief
Weekly report on AI regulations, safety standards, government policies, and compliance requirements worldwide.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Avenda Health Brings Unfold AI Maps Into Prostate Surgery
UK Medicines Regulator Plans AI Safety Tools by 2030
AnX Robotica Cites 88.6% ProScan Review Time Reduction
SimBioSys Gets FDA Clearance for AI Breast Cancer Recurrence Tool
AIRS Medical Gets FDA Clearance for MRI Body Composition Tool
Daily AI Brief: the AI news that matters, in your inbox.